[
  {
    "ts": null,
    "headline": "Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs",
    "summary": "LONDON, January 29, 2026--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science",
    "url": "https://finnhub.io/api/news?id=f5ee96f36fe64dac6db92f5fd351ae12740084baca15ddb831eb902480dc503a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769695200,
      "headline": "Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs",
      "id": 138295707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "LONDON, January 29, 2026--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science",
      "url": "https://finnhub.io/api/news?id=f5ee96f36fe64dac6db92f5fd351ae12740084baca15ddb831eb902480dc503a"
    }
  },
  {
    "ts": null,
    "headline": "DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets",
    "summary": "Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per share was 1.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=faf6d1cb3a7a17a555be8bdea02da2b199c99023e916c594a83d05c8801e3e1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769664696,
      "headline": "DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets",
      "id": 138298587,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per share was 1.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=faf6d1cb3a7a17a555be8bdea02da2b199c99023e916c594a83d05c8801e3e1c"
    }
  },
  {
    "ts": null,
    "headline": "Danaher annual profit declines but sales improve on stronger quarter",
    "summary": "Danaher annual profit declines but sales improve on stronger quarter",
    "url": "https://finnhub.io/api/news?id=80e91ebac28bf1968ab4f9f5379d36a74c88effdb53c1d14ccf4b6e332921d3c",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769644882,
      "headline": "Danaher annual profit declines but sales improve on stronger quarter",
      "id": 138290518,
      "image": "",
      "related": "DHR",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=80e91ebac28bf1968ab4f9f5379d36a74c88effdb53c1d14ccf4b6e332921d3c"
    }
  }
]